StreetAlpha
13F holdings · Q3 2026

Eagle Health Investments

Greenwich, CT · files as Eagle Health Investments LP
Know the moment Eagle Health Investments filesYou follow Eagle Health Investments An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1842545

Eagle Health Investments reported 22 stocks worth $582M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are ARGX (12.6%), GH (9.2%) and ICLR (7.7%). Compared with Q2 2026, the fund opened new positions in UTHR, ROIV and REPL, added to ARGX, ISRG and SRRK, trimmed ICLR, INSM and KYMR and sold out of BMRN, ILMN and RARE.

Latest filing: what Eagle Health Investments did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
4 new5 added3 trimmed9 sold outBought about $137M · sold about $160M
New 4
Added 5
Trimmed 3
Sold out 9
See all 9 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$582M−3.6% vs last quarter · $609M including options
Stocks held224 new · 9 sold out
Top 5 weight44.6%fairly concentrated
Turnover51%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
ARGX
Argenx SE
$73.4M12.6%77K+176 (+0%)8 of 8
2
GH
Guardant Health Inc
$53.6M9.2%301KNo change6 of 8
3
ICLR
Icon PLC
$45M7.7%265K−43K (−14%)8 of 8
4
ISRG
Intuitive Surgical Inc
$44.1M7.6%109K+104K (+2373%)8 of 8
5
UTHR
United Therapeutics Corp Del
$43.2M7.4%80KNew position2 of 8
6
INSM
Insmed Inc
$40.9M7.0%359K−25K (−7%)8 of 8
7
PTGX
Protagonist Therapeutics Inc
$35M6.0%248KNo change4 of 8
8
ROIV
Roivant Sciences Ltd
$32.2M5.5%879KNew position1 of 8
9
SRRK
Scholar Rock Hldg Corp
$27.1M4.7%562K+6,255 (+1%)6 of 8
10
ASND
Ascendis Pharma A/s
$27M4.7%119K+12K (+12%)2 of 8
🔒 12 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
BMRN
Biomarin Pharmaceutical Inc
$35.7M625K
ILMN
Illumina Inc
$33M187K
RARE
Ultragenyx Pharmaceutical in
$29.5M884K
IONS
Ionis Pharmaceuticals Inc
$15.4M195K
TEM
Tempus AI Inc
$14.8M256K

🔒 Free account: see all 9.

Options

valued at the underlying shares
StockTypeValueSharesChange
GH
Guardant Health Inc
Put$26.8M150K+150,300

Reported value

last 8 quarters
$408MQ4 '24
$385MQ1 '25
$405MQ2 '25
$381MQ3 '25
$455MQ4 '25
$476MQ1 '26
$603MQ2 '26
$582MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Eagle Health Investments 13F FAQ

What does Eagle Health Investments own?

Eagle Health Investments reported 22 stocks worth $582M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are ARGX (12.6%), GH (9.2%) and ICLR (7.7%). The table above lists every position in the filing (the top 10 without an account).

What did Eagle Health Investments buy and sell in Q3 2026?

Compared with Q2 2026: 4 new positions, 5 added to, 3 trimmed and 9 sold out. New positions include UTHR, ROIV and REPL. It sold all of BMRN, ILMN and RARE.

When will Eagle Health Investments file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Eagle Health Investments's portfolio worth?

The Q3 2026 filing reports $582M in US stocks ($609M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.